Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
19M
-
Shares change
-
+388K
-
Total reported value, excl. options
-
$183M
-
Value change
-
+$4.26M
-
Number of buys
-
28
-
Number of sells
-
-27
-
Price
-
$9.66
Significant Holders of Apyx Medical Corp - Common Stock (APYX) as of Q1 2021
69 filings reported holding APYX - Apyx Medical Corp - Common Stock as of Q1 2021.
Apyx Medical Corp - Common Stock (APYX) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19M shares
of 35M outstanding shares and own 54.2% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3.39M shares), Archon Capital Management LLC (2.45M shares), BlackRock Inc. (2.42M shares), VANGUARD GROUP INC (1.47M shares), PURA VIDA INVESTMENTS, LLC (958K shares), JPMORGAN CHASE & CO (817K shares), HORIZON KINETICS ASSET MANAGEMENT LLC (615K shares), Taylor Frigon Capital Management LLC (612K shares), ROYCE & ASSOCIATES LP (559K shares), and COWEN AND COMPANY, LLC (522K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.